Overview
SLU-PP-332 is a synthetic small-molecule compound utilised in laboratory research involving estrogen-related receptor (ERR) pathways, particularly ERRα and ERRγ, and associated signalling systems.
SLU-PP-332, chemically known as (E)-4-Hydroxy-N′-(naphthalen-2-ylmethylene)benzohydrazide, is a non-hormonal small molecule used in controlled research environments as a model compound in studies involving ERR-associated pathways, receptor interaction systems, and transcription-related signalling models.
Chemical reference information: CAS number: 303760-60-3; Molecular formula: C₁₈H₁₄N₂O₂; Molecular weight: 290.32 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
SLU-PP-332 10 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Handling and storage
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.